Clinical Trial Update: Neurocognitive Decline in Patients With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

The document outlines a Phase 1/2 clinical trial evaluating neurocognitive decline in patients with brain metastases. The study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Brain Metastases | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING